TSXV/JNH (TSXV/JNH)

TSX Venture Exchange: TSXV/JNH · CAD

CA$0.01

+0.00 (0.0%)· Recorded snapshot

Market cap	871K
Revenue (ttm)	-6.7M
Net income (ttm)	10.6M
EPS (ttm)	CA$0.11
Shares out	87.1M
P/E (trailing)	0.1x
Volume	0
Beta	-0.31

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): -6.7M
Net income (ttm): 10.6M
EPS (ttm): CA$0.11
P/E (trailing): 0.1x
Market cap: 871K

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-30 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E0.1

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROICn/a

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All TSXV/JNH indicators

Market & fundamental data

Available fields

151

Groups with data

Currency

CAD

Showing 151 of 151 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-10-09
Enterprise value	CAD 14.4M
Exchange	TSX Venture Exchange
Financial currency	CAD
Financial report date	2025-10-31
First seen	2026-05-10
Fiscal year end	January
Founded	2006
Industry	Medical Care Facilities
Is primary listing	Yes
ISIN number	CA4663771083
Last earnings date	2026-01-02
Last refreshed	2026-10-30
Last stock split date	2020-10-06
Last stock split type	Reverse
Market cap	CAD 870,992
Price	CAD 0.01
Price currency	CAD
Sector	Healthcare
SIC code	8011
Stock price date	2025-06-06
Symbol	tsxv/JNH

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	1,142%
EV/Earnings	1.36x
EV/EBIT	26.46x
EV/EBITDA	18.6x
FCF / EV yield	-17.05%
FCF yield	-281.33%
Industry forward P/E	19.47x
Industry P/E	27.06x
P/E ratio	0.09x
Price/EBITDA ratio	1.26x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Operating margin	-8.09%
Pretax margin	-7.04%
Profitable years	1
ROA	9.45%
ROA (5Y)	-26.41%
ROCE	-38.63%
SBC / revenue	-0.01%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	4
EPS growth years	0
Net income growth quarters	4
Net income growth years	4
Operating income growth 5Y	3.64%
Revenue growth	26.41%
Revenue growth (Q)	-98.37%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CAD -580,700
Depreciation and amortization	CAD 149,279
EBIT	CAD 543,067
EBITDA	CAD 692,346
EPS	CAD 0.11
FCF per share	CAD -0.03
Financing cash flow	CAD -613,044
Free cash flow	CAD -2.5M
Free cash flow minus SBC	CAD -2.5M
Gross profit	CAD -5.4M
Income taxes	CAD -88,555
Investing cash flow	CAD 5M
Net borrowing	CAD -358,044
Net cash flow	CAD 2.6M
Net income	CAD 10.6M
Operating cash flow minus SBC	CAD -1.9M
Operating income	CAD 543,067
Revenue	CAD -6.7M
Stock-based compensation	CAD 540

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-88.93
Book value per share	CAD -0.02
Debt / EBITDA	0.26
Long-term assets	CAD 305,421
Long-term liabilities	CAD 634,492
Net cash (debt)	CAD -387,521
Net cash / market cap	-44.49%
Net debt / EBITDA	0.56
Piotroski F-Score	2
Property, plant and equipment	CAD 305,421
Shareholders' equity	CAD -2M
Tangible book value	CAD -2M
Tangible book value per share	CAD -0.02
Total assets	CAD 526,362
Total cash	CAD -188,803
Total debt	CAD 198,718
Total liabilities	CAD 2.6M
WACC	2.06%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	CAD 220,941
Current liabilities	CAD 1.9M
Current ratio	0.11
Net working capital	CAD -1.5M
Quick ratio	0.07
Working capital	CAD -1.7M
Working capital turnover	2.14

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.38%
Shareholder yield	-0.38%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CAD 0.02
1D price change	0%
1M price change	100%
1M total return	100%
1W price change	100%
1W total return	100%
1Y price change	-75%
1Y return CAGR	-75.02%
1Y total return	-75%
20-day SMA	CAD 0.01
200-day SMA	CAD 0.03
3M price change	-50%
3M total return	-50%
3Y price change	-93.33%
3Y return CAGR	-59.44%
3Y total return	-93.33%
50-day SMA	CAD 0.01
50-day SMA vs 200-day SMA	50under200
52-week high	CAD 0.05
52-week high date	2024-08-28
52-week low	CAD 0.01
52-week low date	2025-06-06
6M price change	-60%
6M total return	-60%
All-time high	CAD 2.72
All-time high date	2020-10-19
All-time low	CAD 0.01
All-time low date	2025-04-14
Average true range (ATR)	CAD 0.00
Average volume	129.5K
Beta (1Y)	0
Beta (2Y)	0.13
Beta (5Y)	-0.31
Change from 52-week high	-80%
Change from 52-week low	100%
Change from all-time high	-99.63%
Change from all-time low	100%
Monthly RSI	26.72
Previous close	CAD 0.01
Price vs 150-day SMA	-59.35%
Price vs 20-day SMA	81.82%
Price vs 200-day SMA	-67.74%
Price vs 50-day SMA	-22.48%
Relative volume	1.85
RSI	54.17
Sharpe ratio	0.92
Sharpe ratio (3Y)	0.28
Sortino ratio	1.65
Sortino ratio (3Y)	0.51
Volume	0
Weekly RSI	38.39
YTD price change	-50%
YTD total return	-50%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Shares change (YoY)	0.38%
Shares outstanding	87.1M

Deeper analysis on TSXV/JNH

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this TSXV/JNH report

Is a complete TSXV/JNH research report available?

No complete published report is available for tsxv/JNH (TSXV/JNH) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TSXV/JNH (TSXV/JNH)

Price

Financial snapshot

Fair-value bridge

Latest news · TSXV/JNH

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TSXV/JNH indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TSXV/JNH

Frequently asked questions